Stem Cell Research in Cardiovascular Diseases

Call for Papers

Cardiovascular disease is a main cause of death in advanced countries. To establish novel therapies and to understand the molecular mechanisms behind incurable cardiovascular illnesses, we generated animal models and screened numerous potential therapeutic targets. Still, there are many incurable cardiovascular diseases remained.

Recent investigations suggest a great potential for stem cells in human therapy. Accordingly, basic and clinical investigations resulted in the discovery and generation of human embryonic (ES) and induced pluripotent (iPS) cardiovascular progenitor cells in 1999 and 2007. iPS cells have promising advantages to generate patient specific pluripotent stem cells allowing their transplantation without immunological problems and to create various genetic disorder models. Now, we are very interested in the potential of stem cells for cardiovascular disease in terms of therapeutic application. This issue focuses on the recent advances of stem cell research in cardiovascular diseases. Potential topics include, but are not limited to:

• Pluripotent stem cell for cardiac regenerative therapy
• Cardiac regenerative therapy by activating innate stem cells
• Cardiac regenerative therapy using adult stem cells

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/sci/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/submit/journals/sci/cvd/ according to the following timetable:

Lead Guest Editor

• Shinsuke Yuasa, Department of Cardiology, Keio University School of Medicine, Japan

Guest Editors

• Ionta Vittoria, Department of Molecular Medicine, Sapienza University of Rome, Italy
• Ildiko Bock-Marquette, University of Pecs Faculty of Medicine, Department of Biochemistry and Medical Chemistry, Hungary